Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taku Okazaki

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Immunology Letters|July 4, 2002
Microanatomical localization of PD-1 in human tonsilsYoshiko Iwai, Taku Okazaki, Hiroyuki Nishimura, et al.
Nature Immunology|February 3, 2005
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4Hans Christian Probst, Kathy McCoy, Taku Okazaki, et al.
The Journal of Biological Chemistry|November 15, 2019
Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cellsNatsumi Maeda, Takumi Maruhashi, Daisuke Sugiura, et al.
Journal of Virology|December 21, 2007
The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndromeKathy A Green, Taku Okazaki, Tasuku Honjo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2021
PD-1 preferentially inhibits the activation of low-affinity T cellsKenji Shimizu, Daisuke Sugiura, Il-Mi Okazaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2011
IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunitySeigo Terawaki, Shunsuke Chikuma, Shiro Shibayama, et al.
Immunology Letters|August 6, 2002
Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissuesMasayoshi Ishida, Yoshiko Iwai, Yoshimasa Tanaka, et al.
Journal of Autoimmunity|July 7, 2019
PD-1 aborts the activation trajectory of autoreactive CD8<sup>+</sup> T cells to prohibit their acquisition of effector functionsHikari Okamura, Il-Mi Okazaki, Kenji Shimizu, et al.
Biochemical and Biophysical Research Communications|February 18, 2019
PD-1 efficiently inhibits T cell activation even in the presence of co-stimulation through CD27 and GITRReina Mizuno, Takumi Maruhashi, Daisuke Sugiura, et al.
The Journal of Experimental Medicine|December 15, 2005
Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b-/-Pdcd1-/- miceTaku Okazaki, Yumi Otaka, Jian Wang, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Immunology Letters|July 4, 2002
Microanatomical localization of PD-1 in human tonsilsYoshiko Iwai, Taku Okazaki, Hiroyuki Nishimura, et al.
Nature Immunology|February 3, 2005
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4Hans Christian Probst, Kathy McCoy, Taku Okazaki, et al.
The Journal of Biological Chemistry|November 15, 2019
Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cellsNatsumi Maeda, Takumi Maruhashi, Daisuke Sugiura, et al.
Journal of Virology|December 21, 2007
The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndromeKathy A Green, Taku Okazaki, Tasuku Honjo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2021
PD-1 preferentially inhibits the activation of low-affinity T cellsKenji Shimizu, Daisuke Sugiura, Il-Mi Okazaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2011
IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunitySeigo Terawaki, Shunsuke Chikuma, Shiro Shibayama, et al.
Immunology Letters|August 6, 2002
Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissuesMasayoshi Ishida, Yoshiko Iwai, Yoshimasa Tanaka, et al.
Journal of Autoimmunity|July 7, 2019
PD-1 aborts the activation trajectory of autoreactive CD8<sup>+</sup> T cells to prohibit their acquisition of effector functionsHikari Okamura, Il-Mi Okazaki, Kenji Shimizu, et al.
Biochemical and Biophysical Research Communications|February 18, 2019
PD-1 efficiently inhibits T cell activation even in the presence of co-stimulation through CD27 and GITRReina Mizuno, Takumi Maruhashi, Daisuke Sugiura, et al.
The Journal of Experimental Medicine|December 15, 2005
Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b-/-Pdcd1-/- miceTaku Okazaki, Yumi Otaka, Jian Wang, et al.
Pageof 6